Investor Relations
TOP IR CONTENTS
The Latest Presentation Materials
Past Presentation MaterialsConference on FY2026.12 Q1 Financial Results
FY2026 Q1 Overview
Dr. Osamu Okuda,
President & CEO
FY2026 Q1 Overview of Development Pipeline
Tsukasa Kusano,
Executive Vice President, Head of Project & Lifecycle Management Unit
FY2026 Q1 Consolidated Financial Overview (Core)
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
Upcoming Events(Upcoming Events (2 Most Recent))
Events & PresentationsAnnual Report 2024(Integrated Report)
Past Annual Report
What's New
-
Temporary Audio Streaming of Conference on FY 2026.12 Q1 Financial Results
-
Conference on FY 2026.12 Q1 Financial Results
-
Financial Results for First Quarter of Fiscal Year 2026 (Jan-Mar 2026)
-
Notice of Resolutions of the 115th Annual General Meeting
-
Notice Regarding Year-End Dividend for the Fiscal Year ending December, 2025
-
Chugai Announces 2026 1st Quarter Results
-
Organizational and Personnel Changes
-
Determination of Details Regarding Share Acquisition Associated with the Introduction of the Trust-Based Stock Compensation System
-
F. Hoffmann-La Roche Announces First Quarter Sales 2026
-
FJ3, API Manufacturing Building for Small Molecule and Macrocyclic Peptide Drugs at the Fujieda Plant, Receives the 2026 Facility of the Year Awards from ISPE in the Honorable Mention Category
External Evaluations
External Evaluations-
ESG Indices of Global Equities
DJSI is a leading ESG index developed by S&P Dow Jones Indices (USA). Companies are selected as a constituent annually based on an assessment of their economic, environmental and social sustainability.
-
ESG Indices Selected by GPIF
Chugai has been continuously included as a constituent stock of the all six ESG indices for Japanese equities since the initiation of ESG investment by the Government Pension Investment Fund (GPIF).
-
IR Activities
Chugai was ranked first for the first time in 2024 in the pharmaceutical sector for the “Selection of Excellent Companies in Corporate Disclosure by Securities Analysts” conducted by the Securities Analysts Association of Japan (SAAJ), a public interest incorporated association.
About Chugai
-
Company Outline
Company Profile, Business Process, Directors & Officers, Organization.
-
History of Chugai Pharmaceutical
Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”
-
R&D
Easy-to-understand introduction of Chugai’s R&D structure, strategies and technologies.
